$16 billion in the United States. Now, capture only a fraction of this and do the math.
Sentiment: Strong Buy
jeezus h kerist , like in the old days , the third string is working the weekends.
"Unmet need remains in neuropathic and nociceptive pain markets due to side effects and abuse liability of existing therapies. Combined sales of ~$16 billion in the U.S. and ~$30 billion worldwide in 2010."
Justhefaks, yes, you are working the weekends. No doubt about it.
Now, I have provided the numbers, YOU do the math.
Did you ever graduate form anything other than AH High?
Capturing 15% of the US pain market alone puts us well above 100 PPS.